Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revvity, Inc. Common Stock
(NY:
RVTY
)
114.72
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Revvity, Inc. Common Stock
< Previous
1
2
Next >
Uncover the latest developments among S&P500 stocks in today's session.
February 10, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations
January 31, 2025
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year revenue...
Via
StockStory
Friday's pre-market session: top gainers and losers in the S&P500 index
January 31, 2025
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.
Via
Chartmill
Earnings Scheduled For January 31, 2025
January 31, 2025
Via
Benzinga
(RVTY) - Analyzing Revvity's Short Interest
January 22, 2025
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Revvity
January 21, 2025
Via
Benzinga
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
December 13, 2024
BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges.
Via
Benzinga
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
November 05, 2024
Via
Benzinga
Assessing Revvity: Insights From 8 Financial Analysts
October 15, 2024
Via
Benzinga
Looking Into Revvity's Recent Short Interest
September 10, 2024
Via
Benzinga
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
July 29, 2024
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024
July 29, 2024
RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance
July 29, 2024
Revvity reported Q2 sales of $691.69 million, surpassing estimates, with adjusted EPS of $1.22. Life Sciences revenue fell 7%, while Diagnostics sales rose 1%. Updated 2024 guidance includes sales of...
Via
Benzinga
4 Analysts Have This To Say About Revvity
April 30, 2024
Via
Benzinga
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
April 29, 2024
RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
The Latest Analyst Ratings For Revvity
January 25, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
January 04, 2024
Via
Benzinga
7 Analysts Have This to Say About Revvity
December 13, 2023
Via
Benzinga
Why Revvity Stock Plunged Today
October 30, 2023
Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know.
Via
The Motley Fool
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
April 29, 2024
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc....
Via
Benzinga
Why Biotechnology Company Revvity's Shares Diving Today
October 30, 2023
Revvity Inc (NYSE: RVTY) shares are trading lower by around 17% after the company reported worse-than-expected Q3 FY23 results and
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 30, 2023
Via
Benzinga
Earnings Outlook For Revvity
October 27, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Revvity
October 17, 2023
Via
Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on...
Via
Benzinga
Earnings Preview For Revvity
January 31, 2024
Via
Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 30, 2023
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.